ArticleJCI insight2022

ARID1A-deficient bladder cancer is dependent on PI3K signaling and sensitive to EZH2 and PI3K inhibitors.

Hasibur Rehman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.